A61K 9/0053
Mouth and digestive tract, i.e. intraoral and peroral administration
Official title: {Mouth and digestive tract, i.e. intraoral and peroral administration}
A61K9/0053 (Mouth and digestive tract, i.e. intraoral and peroral administration) appears on 13,628 US grants and 24,982 published applications in this corpus.
Search patents in A61K- Granted patents
- 13,628
- Published applications
- 24,982
- Assignees
- 7,399
- Inventors
- 31,605
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 11 | 0 |
| 1977 | 9 | 0 |
| 1978 | 10 | 0 |
| 1979 | 28 | 0 |
| 1980 | 14 | 0 |
| 1981 | 19 | 0 |
| 1982 | 9 | 0 |
| 1983 | 9 | 0 |
| 1984 | 8 | 0 |
| 1985 | 10 | 0 |
| 1986 | 23 | 0 |
| 1987 | 35 | 0 |
| 1988 | 51 | 0 |
| 1989 | 75 | 0 |
| 1990 | 50 | 0 |
| 1991 | 56 | 0 |
| 1992 | 57 | 0 |
| 1993 | 54 | 0 |
| 1994 | 51 | 0 |
| 1995 | 38 | 0 |
| 1996 | 54 | 0 |
| 1997 | 71 | 0 |
| 1998 | 86 | 0 |
| 1999 | 95 | 0 |
| 2000 | 79 | 0 |
| 2001 | 111 | 49 |
| 2002 | 118 | 157 |
| 2003 | 115 | 279 |
| 2004 | 81 | 304 |
| 2005 | 64 | 334 |
| 2006 | 75 | 325 |
| 2007 | 58 | 373 |
| 2008 | 58 | 388 |
| 2009 | 61 | 376 |
| 2010 | 132 | 471 |
| 2011 | 138 | 511 |
| 2012 | 231 | 545 |
| 2013 | 296 | 679 |
| 2014 | 439 | 870 |
| 2015 | 537 | 985 |
| 2016 | 727 | 1580 |
| 2017 | 869 | 1796 |
| 2018 | 881 | 1424 |
| 2019 | 924 | 1886 |
| 2020 | 1065 | 2177 |
| 2021 | 1166 | 2150 |
| 2022 | 1080 | 1725 |
| 2023 | 991 | 1675 |
| 2024 | 968 | 1598 |
| 2025 | 878 | 1272 |
| 2026 | 563 | 1053 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method and apparatus for delivering an API-containing liquid to an edible substrate6 Oct 2026US 12,751,915 B2Transport Authority, Inc.
- Hydrogels as oral delivery dosage forms, methods of making and using same6 Oct 2026US 12,751,917 B2VeraMorph LLC
- Compositions comprising curcuminoids for use in the treatment of muscle soreness6 Oct 2026US 12,751,932 B2Givaudan SA
- Oral liquid formulation of apixaban6 Oct 2026US 12,751,947 B2Liqmeds Worldwide Limited
- Dosage forms for TYK2 inhibitors6 Oct 2026US 12,751,948 B2Bristol-Myers Squibb Company
- A consumable gel for health ingredients8 Oct 2026US 2026/0306399 A1Gelteq Limited
- Aqueous formulations comprising fullerene, structured water, dissolved hydrogen gas, minerals and additives8 Oct 2026US 2026/0306402 A1Best Planet Science LLC
- Drug-polymer amorphous solid dispersions using linear polyacrylic acid polymers8 Oct 2026US 2026/0306410 A1Lubrizol Advanced Materials, Inc.
- Oral targeted nano delivery systems containing geniposide and preparation methods thereof8 Oct 2026US 2026/0306417 A1Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
Most cited
By later US patents
- Gum pad for delivery of medication to mucosal tissues1,140US 6,319,510 B12001
- Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation733US 9,101,621 B2Celgene Corporation · 2015
- Controlled release powder and process for its preparation660US 5,354,556 AElan Corporation, plc · 1994
- Method of moving a delivery member of a dispensing device for administration of oral transmucosal dosage forms654US 8,499,966 B2AcelRx Pharmaceuticals, Inc. · 2013
- Biodegradable polymer composition425US 5,324,519 AAtrix Laboratories, Inc. · 1994